Tuesday, May 11, 2021 1:02:36 PM
$NPHC Next video in our series. This is an introduction to our Chief Scientific Officer, Dale Vanderputten, PhD. Dr. Vanderputten has a PhD in genetics and has been working in drug development for over 20 years! More videos coming soon. #Nyloxin #MS #PetPainAway #LuxuryFeet pic.twitter.com/qYROwwTEg8
— Nutra Pharma (@nutrapharma) May 11, 2021
$NPHC Next video in our series. This is an introduction to our Chief Scientific Officer, Dale Vanderputten, PhD. Dr. Vanderputten has a PhD in genetics and has been working in drug development for over 20 years! More videos coming soon. #Nyloxin #MS #PetPainAway #LuxuryFeet
At least this video isn't Ric again - we can finally meet Vanderputten.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM